Literature DB >> 3076068

The normal human H-ras1 gene can act as an onco-suppressor.

A Spandidos1, N M Wilkie.   

Abstract

The altered morphology and tumorigenic phenotypes of rat 208F fibroblasts transformed with the human T24 H-ras1 oncogene is suppressed by transfection with the human normal H-ras1 gene. In the suppressed cells, both the normal and mutant T24 ras gene products are expressed although the normal p21 is expressed at a higher level. Rare transformants or tumours derived from suppressed cells possess reduced expression of normal ras p21. Our findings suggest that transforming ras alleles do not behave in a dominant manner and that elevated expression of the normal allele could cause suppression of the morphologically transformed and tumorigenic phenotypes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3076068      PMCID: PMC2149125     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  24 in total

1.  A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants.

Authors:  M Trahey; F McCormick
Journal:  Science       Date:  1987-10-23       Impact factor: 47.728

2.  Electric field-mediated gene transfer (electroporation) into mouse Friend and human K562 erythroleukemic cells.

Authors:  D A Spandidos
Journal:  Gene Anal Tech       Date:  1987 May-Jun

3.  A case for human tumor-suppressor genes.

Authors:  E J Stanbridge
Journal:  Bioessays       Date:  1985-12       Impact factor: 4.345

Review 4.  The molecular genetics of cancer.

Authors:  J M Bishop
Journal:  Science       Date:  1987-01-16       Impact factor: 47.728

Review 5.  A unified theory for the development of cancer.

Authors:  D A Spandidos
Journal:  Biosci Rep       Date:  1986-08       Impact factor: 3.840

6.  Malignant transformation of early passage rodent cells by a single mutated human oncogene.

Authors:  D A Spandidos; N M Wilkie
Journal:  Nature       Date:  1984 Aug 9-15       Impact factor: 49.962

7.  Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells.

Authors:  H Paterson; B Reeves; R Brown; A Hall; M Furth; J Bos; P Jones; C Marshall
Journal:  Cell       Date:  1987-12-04       Impact factor: 41.582

8.  Expression of normal and mutant ras proteins in human acute leukemia.

Authors:  W P Shen; T H Aldrich; G Venta-Perez; B R Franza; M E Furth
Journal:  Oncogene       Date:  1987-05       Impact factor: 9.867

9.  Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient.

Authors:  E Santos; D Martin-Zanca; E P Reddy; M A Pierotti; G Della Porta; M Barbacid
Journal:  Science       Date:  1984-02-17       Impact factor: 47.728

Review 10.  Genetics of human cancer.

Authors:  A G Knudson
Journal:  Annu Rev Genet       Date:  1986       Impact factor: 16.830

View more
  9 in total

Review 1.  Intersectin scaffold proteins and their role in cell signaling and endocytosis.

Authors:  Erika Herrero-Garcia; John P O'Bryan
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2016-10-12       Impact factor: 4.739

2.  Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors.

Authors:  A B Bianchi; C M Aldaz; C J Conti
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 3.  The Mystery of Rap1 Suppression of Oncogenic Ras.

Authors:  Ruth Nussinov; Hyunbum Jang; Mingzhen Zhang; Chung-Jung Tsai; Anna A Sablina
Journal:  Trends Cancer       Date:  2020-03-02

Review 4.  The role of wild type RAS isoforms in cancer.

Authors:  Bingying Zhou; Channing J Der; Adrienne D Cox
Journal:  Semin Cell Dev Biol       Date:  2016-07-13       Impact factor: 7.727

5.  Wild-type K-ras has a tumour suppressor effect on carcinogen-induced murine colorectal adenoma formation.

Authors:  Feijun Luo; George Poulogiannis; Hongtao Ye; Rifat Hamoudi; Gehong Dong; Wenyan Zhang; Ashraf E K Ibrahim; Mark J Arends
Journal:  Int J Exp Pathol       Date:  2013-12-20       Impact factor: 1.925

6.  A new dimension to Ras function: a novel role for nucleotide-free Ras in Class II phosphatidylinositol 3-kinase beta (PI3KC2β) regulation.

Authors:  Katy A Wong; Angela Russo; Xuerong Wang; Yun-Ju Chen; Arnon Lavie; John P O'Bryan
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

7.  Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer.

Authors:  Shuang Bai; Qiang Feng; Xin-Yan Pan; Hong Zou; Hao-Bin Chen; Peng Wang; Xin-Liang Zhou; Yan-Ling Hong; Shu-Ling Song; Ju-Lun Yang
Journal:  Int J Mol Med       Date:  2017-02-21       Impact factor: 4.101

Review 8.  Emerging roles for intersectin (ITSN) in regulating signaling and disease pathways.

Authors:  Michael P Hunter; Angela Russo; John P O'Bryan
Journal:  Int J Mol Sci       Date:  2013-04-10       Impact factor: 5.923

9.  Clinical Virology research and medical education in Greece: An interview with Demetrios A. Spandidos, Professor of Clinical Virology at the University of Crete in Greece.

Authors:  Ioannis N Mammas
Journal:  Exp Ther Med       Date:  2019-08-28       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.